{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T10:53:06Z","timestamp":1776509586480,"version":"3.51.2"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007797","name":"University of Helsinki","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-025-08778-x","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T01:30:31Z","timestamp":1741915831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Empowerment and mobile technology in the detection and treatment of main cardiovascular risk factors of patients with ischemic stroke or transient ischemic attack: a protocol for a multicenter randomized controlled trial (CARDIOSTROKE)"],"prefix":"10.1186","volume":"26","author":[{"given":"T.","family":"Lumikari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Putaala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Pirinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kerola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Sibolt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Granroth-Wilding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Pakarinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lehto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Nieminen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"issue":"8","key":"8778_CR1","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1161\/CIR.0000000000000950","volume":"143","author":"SS Virani","year":"2021","unstructured":"Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. Heart disease and stroke statistics\u20142021 update. Circulation. 2021;143(8):e146.","journal-title":"Circulation"},{"issue":"8","key":"8778_CR2","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1161\/STROKEAHA.120.028992","volume":"51","author":"C Flach","year":"2020","unstructured":"Flach C, Muruet W, Wolfe CDA, Bhalla A, Douiri A. Risk and secondary prevention of stroke recurrence. Stroke. 2020;51(8):2435\u201344.","journal-title":"Stroke"},{"issue":"4","key":"8778_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/2396987318808719","volume":"3","author":"B Norrving","year":"2018","unstructured":"Norrving B, Barrick J, Davalos A, Dichgans M, Cordonnier C, Guekht A, et al. Action plan for stroke in Europe 2018\u20132030. Eur Stroke J. 2018;3(4):309\u201336.","journal-title":"Eur Stroke J"},{"issue":"10046","key":"8778_CR4","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0140-6736(16)30506-2","volume":"388","author":"MJ O\u2019Donnell","year":"2016","unstructured":"O\u2019Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388(10046):761\u201375.","journal-title":"Lancet"},{"issue":"may19 1","key":"8778_CR5","doi-asserted-by":"publisher","first-page":"b1665\u2013b1665","DOI":"10.1136\/bmj.b1665","volume":"338","author":"MR Law","year":"2009","unstructured":"Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338(may19 1):b1665\u2013b1665.","journal-title":"BMJ"},{"issue":"4","key":"8778_CR6","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1161\/STROKEAHA.121.035851","volume":"53","author":"IJ McGurgan","year":"2022","unstructured":"McGurgan IJ, Kelly PJ, Turan TN, Rothwell PM. Long-term secondary prevention: management of blood pressure after a transient ischemic attack or stroke. Stroke. 2022;53(4):1085\u2013103.","journal-title":"Stroke"},{"issue":"10124","key":"8778_CR7","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S0140-6736(18)30309-X","volume":"391","author":"RJ McManus","year":"2018","unstructured":"McManus RJ, Mant J, Franssen M, Nickless A, Schwartz C, Hodgkinson J, et al. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. Lancet. 2018;391(10124):949\u201359.","journal-title":"Lancet"},{"issue":"8","key":"8778_CR8","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1001\/jama.2014.10057","volume":"312","author":"RJ McManus","year":"2014","unstructured":"McManus RJ, Mant J, Haque MS, Bray EP, Bryan S, Greenfield SM, et al. Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease. JAMA. 2014;312(8):799.","journal-title":"JAMA"},{"issue":"7515","key":"8778_CR9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1136\/bmj.38558.393669.E0","volume":"331","author":"RJ McManus","year":"2005","unstructured":"McManus RJ, Mant J, Roalfe A, Oakes RA, Bryan S, Pattison HM, et al. Targets and self monitoring in hypertension: randomised controlled trial and cost effectiveness analysis. BMJ. 2005;331(7515):493.","journal-title":"BMJ"},{"issue":"1","key":"8778_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1001\/jama.2013.6549","volume":"310","author":"KL Margolis","year":"2013","unstructured":"Margolis KL, Asche SE, Bergdall AR, Dehmer SP, Groen SE, Kadrmas HM, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control. JAMA. 2013;310(1):46.","journal-title":"JAMA"},{"issue":"2","key":"8778_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/fampra\/cmp094","volume":"27","author":"M Godwin","year":"2010","unstructured":"Godwin M, Lam M, Birtwhistle R, Delva D, Seguin R, Casson I, et al. A primary care pragmatic cluster randomized trial of the use of home blood pressure monitoring on blood pressure levels in hypertensive patients with above target blood pressure. Fam Pract. 2010;27(2):135\u201342.","journal-title":"Fam Pract"},{"issue":"10","key":"8778_CR12","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1093\/ajh\/hpv008","volume":"28","author":"BR Fletcher","year":"2015","unstructured":"Fletcher BR, Hartmann-Boyce J, Hinton L, McManus RJ. The effect of self-monitoring of blood pressure on medication adherence and lifestyle factors: a systematic review and meta-analysis. Am J Hypertens. 2015;28(10):1209\u201321.","journal-title":"Am J Hypertens"},{"issue":"1","key":"8778_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13063-015-0628-y","volume":"16","author":"J Hanley","year":"2015","unstructured":"Hanley J, Fairbrother P, Krishan A, McCloughan L, Padfield P, Paterson M, et al. Mixed methods feasibility study for a trial of blood pressure telemonitoring for people who have had stroke\/transient ischaemic attack (TIA). Trials. 2015;16(1):117.","journal-title":"Trials"},{"issue":"1","key":"8778_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1503\/cmaj.120832","volume":"185","author":"SM Kerry","year":"2013","unstructured":"Kerry SM, Markus HS, Khong TK, Cloud GC, Tulloch J, Coster D, et al. Home blood pressure monitoring with nurse-led telephone support among patients with hypertension and a history of stroke: a community-based randomized controlled trial. Can Med Assoc J. 2013;185(1):23\u201331.","journal-title":"Can Med Assoc J"},{"issue":"10","key":"8778_CR15","first-page":"681","volume":"31","author":"JF Potter","year":"2017","unstructured":"Potter JF, Davison W, Clark A, Langley M, Myint P. Does blood pressure self-monitoring with or without supervised antihypertensive treatment modification improve blood pressure (BP) control following stroke or TIA? - the TEST-BP trial. J Hum Hypertens. 2017;31(10):681\u20132.","journal-title":"J Hum Hypertens"},{"issue":"6","key":"8778_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1177\/1747493017700663","volume":"12","author":"G Ntaios","year":"2017","unstructured":"Ntaios G, Papavasileiou V, Diener HC, Makaritsis K, Michel P. Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized controlled trials. Int J Stroke. 2017;12(6):589\u201396.","journal-title":"Int J Stroke"},{"issue":"2","key":"8778_CR17","doi-asserted-by":"publisher","first-page":"e002081","DOI":"10.1136\/openhrt-2022-002081","volume":"9","author":"H Jiang","year":"2022","unstructured":"Jiang H, Tan SY, Wang JK, Li J, Tu TM, Tan VH, et al. A meta-analysis of extended ECG monitoring in detection of atrial fibrillation in patients with cryptogenic stroke. Open Heart. 2022;9(2):e002081.","journal-title":"Open Heart"},{"issue":"1","key":"8778_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13063-016-1743-0","volume":"18","author":"T Li","year":"2017","unstructured":"Li T, Boutron I, Salman RAS, Cobo E, Flemyng E, Grimshaw JM, et al. Review and publication of protocol submissions to Trials \u2013 what have we learned in 10 years? Trials. 2017;18(1):34.","journal-title":"Trials"},{"issue":"jan08 15","key":"8778_CR19","doi-asserted-by":"publisher","first-page":"e7586\u2013e7586","DOI":"10.1136\/bmj.e7586","volume":"346","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346(jan08 15):e7586\u2013e7586.","journal-title":"BMJ"},{"issue":"9558","key":"8778_CR20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(07)60150-0","volume":"369","author":"SC Johnston","year":"2007","unstructured":"Johnston SC, Rothwell PM, Nguyen-Huynh MN, Giles MF, Elkins JS, Bernstein AL, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet. 2007;369(9558):283\u201392.","journal-title":"Lancet"},{"issue":"5","key":"8778_CR21","doi-asserted-by":"publisher","first-page":"e12649","DOI":"10.1111\/anec.12649","volume":"24","author":"TJ Lumikari","year":"2019","unstructured":"Lumikari TJ, Putaala J, Kerola A, Sibolt G, Pirinen J, Pakarinen S, et al. Continuous 4-week ECG monitoring with adhesive electrodes reveals AF in patients with recent embolic stroke of undetermined source. Ann Noninvasive Electrocardiol. 2019;24(5):e12649.","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"6","key":"8778_CR22","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","volume":"75","author":"T Unger","year":"2020","unstructured":"Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334\u201357.","journal-title":"Hypertension"},{"issue":"1","key":"8778_CR23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s13063-022-06316-7","volume":"23","author":"R Qureshi","year":"2022","unstructured":"Qureshi R, Gough A, Loudon K. The SPIRIT checklist\u2014lessons from the experience of SPIRIT protocol editors. Trials. 2022;23(1):359.","journal-title":"Trials"},{"issue":"4","key":"8778_CR24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S1474-4422(15)70027-X","volume":"14","author":"LA Sposato","year":"2015","unstructured":"Sposato LA, Cipriano LE, Saposnik G, Vargas ER, Riccio PM, Hachinski V. Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol. 2015;14(4):377\u201387.","journal-title":"Lancet Neurol"},{"issue":"9","key":"8778_CR25","doi-asserted-by":"publisher","first-page":"e1002389","DOI":"10.1371\/journal.pmed.1002389","volume":"14","author":"KL Tucker","year":"2017","unstructured":"Tucker KL, Sheppard JP, Stevens R, Bosworth HB, Bove A, Bray EP, et al. Self-monitoring of blood pressure in hypertension: a systematic review and individual patient data meta-analysis. PLoS Med. 2017;14(9):e1002389.","journal-title":"PLoS Med"},{"issue":"3","key":"8778_CR26","doi-asserted-by":"publisher","first-page":"e0229483","DOI":"10.1371\/journal.pone.0229483","volume":"15","author":"BJ Kim","year":"2020","unstructured":"Kim BJ, Park JM, Park TH, Kim J, Lee J, Lee KJ, et al. Remote blood pressure monitoring and behavioral intensification for stroke: a randomized controlled feasibility trial. PLoS One. 2020;15(3):e0229483.","journal-title":"PLoS One"},{"key":"8778_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ahj.2018.06.002","volume":"203","author":"WJ Davison","year":"2018","unstructured":"Davison WJ, Myint PK, Clark AB, Kim LG, Langley M, Potter JF. Does self-monitoring and self-management of blood pressure after stroke or transient ischemic attack improve control? TEST-BP, a randomized controlled trial. Am Heart J. 2018;203:105\u20138.","journal-title":"Am Heart J"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-08778-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-08778-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-08778-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T13:11:07Z","timestamp":1741957867000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-025-08778-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8778"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-08778-x","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]},"assertion":[{"value":"11 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was obtained from the Ethics Committee of the Hospital District of Helsinki and Uusimaa. All authors have been approved to conduct research in the trial. Written informed consent will be signed by each participant who is included in the trial.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors have no competing interests to declare. Trial funder has no role in trial planning, data collection, or data analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}